The first survey of gap between the actual labelling and efficacy information of functional substances in food under the regulatory processes in Japan

Research output: Contribution to journalArticle

Abstract

To make well-informed choices, consumers need access to reliable and clear messages regarding the benefits of functional substances in food. This study identified foods with function claims (FFCs) in Japan that had a gap between actual labeling and efficacy information of functional substances not visible on their food package. Between April 1, 2015, to July 20, 2018, 1,310 FFCs were submitted to the regulatory agency and analyzed. The proportion of FFCs with a gap was highest in the health claim category of blood pressure management (79.5%), followed by neutral fat reduction in blood (75%) and suppression of blood sugar spikes (73.4%). These gaps are attributable to differences in food development strategy. Thus, to ensure the quality of benefit communication on FFC to consumers, scientific evidence regarding health claims of functional substances should be managed in an integrated manner.

Original languageEnglish
Article number104047
JournalJournal of Functional Foods
Volume72
DOIs
Publication statusPublished - 2020 Sep

Keywords

  • Active ingredient
  • Efficacy
  • Food labeling
  • Food regulation
  • Foods with function claims
  • Japan

ASJC Scopus subject areas

  • Food Science
  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Fingerprint Dive into the research topics of 'The first survey of gap between the actual labelling and efficacy information of functional substances in food under the regulatory processes in Japan'. Together they form a unique fingerprint.

  • Cite this